APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Drug and Device Microbiological Sterility Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Drug and Device Microbiological Sterility Testing Market Outlook and Growth Opportunities 2026

6 March 2026194 pages

Choose your research edition.

Industry ResearchMedical Drug and Device Microbiological Sterility Testing Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Drug and Device Microbiological Sterility Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Medical Drug and Device Microbiological Sterility Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Drug and Device Microbiological Sterility Testing Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Drug and Device Microbiological Sterility Testing Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Medical Drug and Device Microbiological Sterility Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Drug and Device Microbiological Sterility Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Drug and Device Microbiological Sterility Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Drug and Device Microbiological Sterility Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Drug and Device Microbiological Sterility Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Drug and Device Microbiological Sterility Testing market include Steris PLC, Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., SGS S.A., Sartorius AG, Sotera Health Company, Pacific Biolabs, Inc., Laboratory Corporation of America Holdings and Almac Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medical Drug and Device Microbiological Sterility Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Drug and Device Microbiological Sterility Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Drug and Device Microbiological Sterility Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Drug and Device Microbiological Sterility Testing market.

Medical Drug and Device Microbiological Sterility Testing Segment by Company

Steris PLC

Charles River Laboratories International, Inc.

Thermo Fisher Scientific, Inc.

SGS S.A.

Sartorius AG

Sotera Health Company

Pacific Biolabs, Inc.

Laboratory Corporation of America Holdings

Almac Group

Pace Analytical Services, LLC

Medical Drug and Device Microbiological Sterility Testing Segment by Type

Bioburden Testing

Sterility Testing

Bacterial Endotoxin Testing

Medical Drug and Device Microbiological Sterility Testing Segment by Application

Medical Drugs

Medical Devices

Medical Drug and Device Microbiological Sterility Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Drug and Device Microbiological Sterility Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Drug and Device Microbiological Sterility Testing key companies, revenue, market share, and recent developments.

3. To split the Medical Drug and Device Microbiological Sterility Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Drug and Device Microbiological Sterility Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Drug and Device Microbiological Sterility Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Drug and Device Microbiological Sterility Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Drug and Device Microbiological Sterility Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Drug and Device Microbiological Sterility Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Drug and Device Microbiological Sterility Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Drug and Device Microbiological Sterility Testing industry.

Chapter 3: Detailed analysis of Medical Drug and Device Microbiological Sterility Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Drug and Device Microbiological Sterility Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Drug and Device Microbiological Sterility Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Drug and Device Microbiological Sterility Testing Industry Trends Table 2. Medical Drug and Device Microbiological Sterility Testing Industry Drivers Table 3. Medical Drug and Device Microbiological Sterility Testing Industry Opportunities and Challenges Table 4. Medical Drug and Device Microbiological Sterility Testing Industry Restraints Table 5. Global Medical Drug and Device Microbiological Sterility Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Drug and Device Microbiological Sterility Testing Revenue Share by Company (2021-2026) Table 7. Global Medical Drug and Device Microbiological Sterility Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Drug and Device Microbiological Sterility Testing Key Company Manufacturing Base & Headquarters Table 9. Global Medical Drug and Device Microbiological Sterility Testing Company, Product Type & Application Table 10. Global Medical Drug and Device Microbiological Sterility Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Drug and Device Microbiological Sterility Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Bioburden Testing Table 15. Significant Companies of Sterility Testing Table 16. Significant Companies of Bacterial Endotoxin Testing Table 17. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type (2021-2026) Table 21. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Medical Drugs Table 23. Significant Companies of Medical Devices Table 24. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application (2021-2026) Table 28. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application (2027-2032) Table 29. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Region (2021-2026) Table 32. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Region (2027-2032) Table 34. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Market Share by Country (2021-2026) Table 37. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Market Share by Country (2027-2032) Table 39. Steris PLC Company Information Table 40. Steris PLC Business Overview Table 41. Steris PLC Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Steris PLC Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 43. Steris PLC Recent Development Table 44. Charles River Laboratories International, Inc. Company Information Table 45. Charles River Laboratories International, Inc. Business Overview Table 46. Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 48. Charles River Laboratories International, Inc. Recent Development Table 49. Thermo Fisher Scientific, Inc. Company Information Table 50. Thermo Fisher Scientific, Inc. Business Overview Table 51. Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 53. Thermo Fisher Scientific, Inc. Recent Development Table 54. SGS S.A. Company Information Table 55. SGS S.A. Business Overview Table 56. SGS S.A. Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. SGS S.A. Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 58. SGS S.A. Recent Development Table 59. Sartorius AG Company Information Table 60. Sartorius AG Business Overview Table 61. Sartorius AG Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Sartorius AG Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 63. Sartorius AG Recent Development Table 64. Sotera Health Company Company Information Table 65. Sotera Health Company Business Overview Table 66. Sotera Health Company Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sotera Health Company Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 68. Sotera Health Company Recent Development Table 69. Pacific Biolabs, Inc. Company Information Table 70. Pacific Biolabs, Inc. Business Overview Table 71. Pacific Biolabs, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Pacific Biolabs, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 73. Pacific Biolabs, Inc. Recent Development Table 74. Laboratory Corporation of America Holdings Company Information Table 75. Laboratory Corporation of America Holdings Business Overview Table 76. Laboratory Corporation of America Holdings Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Laboratory Corporation of America Holdings Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 78. Laboratory Corporation of America Holdings Recent Development Table 79. Almac Group Company Information Table 80. Almac Group Business Overview Table 81. Almac Group Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Almac Group Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 83. Almac Group Recent Development Table 84. Pace Analytical Services, LLC Company Information Table 85. Pace Analytical Services, LLC Business Overview Table 86. Pace Analytical Services, LLC Medical Drug and Device Microbiological Sterility Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pace Analytical Services, LLC Medical Drug and Device Microbiological Sterility Testing Product Portfolio Table 88. Pace Analytical Services, LLC Recent Development Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Medical Drug and Device Microbiological Sterility Testing Product Image Figure 2. Global Medical Drug and Device Microbiological Sterility Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Drug and Device Microbiological Sterility Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Drug and Device Microbiological Sterility Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Bioburden Testing Image Figure 8. Sterility Testing Image Figure 9. Bacterial Endotoxin Testing Image Figure 10. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type (2021-2032) Figure 13. Medical Drugs Image Figure 14. Medical Devices Image Figure 15. Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application (2021-2032) Figure 18. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Medical Drug and Device Microbiological Sterility Testing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Medical Drug and Device Microbiological Sterility Testing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Medical Drug and Device Microbiological Sterility Testing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Medical Drug and Device Microbiological Sterility Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Bioburden Testing
  • Sterility Testing
  • Bacterial Endotoxin Testing
Applications
  • Medical Drugs
  • Medical Devices
Companies covered
  • Steris PLC
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific, Inc.
  • SGS S.A.
  • Sartorius AG
  • Sotera Health Company
  • Pacific Biolabs, Inc.
  • Laboratory Corporation of America Holdings
  • Almac Group
  • Pace Analytical Services, LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Drug and Device Microbiological Sterility Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Drug and Device Microbiological Sterility Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Drug and Device Microbiological Sterility Testing Market Dynamics
  1. 2.1 Medical Drug and Device Microbiological Sterility Testing Industry Trends
  2. 2.2 Medical Drug and Device Microbiological Sterility Testing Industry Drivers
  3. 2.3 Medical Drug and Device Microbiological Sterility Testing Industry Opportunities and Challenges
  4. 2.4 Medical Drug and Device Microbiological Sterility Testing Industry Restraints
3 Medical Drug and Device Microbiological Sterility Testing Market by Company
  1. 3.1 Global Medical Drug and Device Microbiological Sterility Testing Company Revenue Ranking in 2025
  2. 3.2 Global Medical Drug and Device Microbiological Sterility Testing Revenue by Company (2021-2026)
  3. 3.3 Global Medical Drug and Device Microbiological Sterility Testing Company Ranking (2024-2026)
  4. 3.4 Global Medical Drug and Device Microbiological Sterility Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Drug and Device Microbiological Sterility Testing Company Product Type and Application
  6. 3.6 Global Medical Drug and Device Microbiological Sterility Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Drug and Device Microbiological Sterility Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Drug and Device Microbiological Sterility Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Drug and Device Microbiological Sterility Testing Market by Type
  1. 4.1 Medical Drug and Device Microbiological Sterility Testing Type Introduction
  2. 4.1.1 Bioburden Testing
  3. 4.1.2 Sterility Testing
  4. 4.1.3 Bacterial Endotoxin Testing
  5. 4.2 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Type
  6. 4.2.1 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type (2021-2032)
5 Medical Drug and Device Microbiological Sterility Testing Market by Application
  1. 5.1 Medical Drug and Device Microbiological Sterility Testing Application Introduction
  2. 5.1.1 Medical Drugs
  3. 5.1.2 Medical Devices
  4. 5.2 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Application
  5. 5.2.1 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application (2021-2032)
6 Medical Drug and Device Microbiological Sterility Testing Regional Value Analysis
  1. 6.1 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Drug and Device Microbiological Sterility Testing Sales Value (2021-2032)
  7. 6.3.2 North America Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Drug and Device Microbiological Sterility Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Drug and Device Microbiological Sterility Testing Sales Value (2021-2032)
  16. 6.6.2 South America Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Drug and Device Microbiological Sterility Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Country, 2025 VS 2032
7 Medical Drug and Device Microbiological Sterility Testing Country-level Value Analysis
  1. 7.1 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Drug and Device Microbiological Sterility Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Drug and Device Microbiological Sterility Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Drug and Device Microbiological Sterility Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Steris PLC
  2. 8.1.1 Steris PLC Company Information
  3. 8.1.2 Steris PLC Business Overview
  4. 8.1.3 Steris PLC Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Steris PLC Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  6. 8.1.5 Steris PLC Recent Developments
  7. 8.2 Charles River Laboratories International, Inc.
  8. 8.2.1 Charles River Laboratories International, Inc. Company Information
  9. 8.2.2 Charles River Laboratories International, Inc. Business Overview
  10. 8.2.3 Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  12. 8.2.5 Charles River Laboratories International, Inc. Recent Developments
  13. 8.3 Thermo Fisher Scientific, Inc.
  14. 8.3.1 Thermo Fisher Scientific, Inc. Company Information
  15. 8.3.2 Thermo Fisher Scientific, Inc. Business Overview
  16. 8.3.3 Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  18. 8.3.5 Thermo Fisher Scientific, Inc. Recent Developments
  19. 8.4 SGS S.A.
  20. 8.4.1 SGS S.A. Company Information
  21. 8.4.2 SGS S.A. Business Overview
  22. 8.4.3 SGS S.A. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SGS S.A. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  24. 8.4.5 SGS S.A. Recent Developments
  25. 8.5 Sartorius AG
  26. 8.5.1 Sartorius AG Company Information
  27. 8.5.2 Sartorius AG Business Overview
  28. 8.5.3 Sartorius AG Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sartorius AG Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  30. 8.5.5 Sartorius AG Recent Developments
  31. 8.6 Sotera Health Company
  32. 8.6.1 Sotera Health Company Company Information
  33. 8.6.2 Sotera Health Company Business Overview
  34. 8.6.3 Sotera Health Company Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sotera Health Company Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  36. 8.6.5 Sotera Health Company Recent Developments
  37. 8.7 Pacific Biolabs, Inc.
  38. 8.7.1 Pacific Biolabs, Inc. Company Information
  39. 8.7.2 Pacific Biolabs, Inc. Business Overview
  40. 8.7.3 Pacific Biolabs, Inc. Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pacific Biolabs, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  42. 8.7.5 Pacific Biolabs, Inc. Recent Developments
  43. 8.8 Laboratory Corporation of America Holdings
  44. 8.8.1 Laboratory Corporation of America Holdings Company Information
  45. 8.8.2 Laboratory Corporation of America Holdings Business Overview
  46. 8.8.3 Laboratory Corporation of America Holdings Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Laboratory Corporation of America Holdings Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  48. 8.8.5 Laboratory Corporation of America Holdings Recent Developments
  49. 8.9 Almac Group
  50. 8.9.1 Almac Group Company Information
  51. 8.9.2 Almac Group Business Overview
  52. 8.9.3 Almac Group Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Almac Group Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  54. 8.9.5 Almac Group Recent Developments
  55. 8.10 Pace Analytical Services, LLC
  56. 8.10.1 Pace Analytical Services, LLC Company Information
  57. 8.10.2 Pace Analytical Services, LLC Business Overview
  58. 8.10.3 Pace Analytical Services, LLC Medical Drug and Device Microbiological Sterility Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pace Analytical Services, LLC Medical Drug and Device Microbiological Sterility Testing Product Portfolio
  60. 8.10.5 Pace Analytical Services, LLC Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst